1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Novel human cancer biomarkers identified by blood cells gene expression
    Meeting Abstract

    Osman, I.; Bajorin, D.; Sun, T. T.; Mikhail, M.; Zhong, H.; Zheng, R.; Han, M.; Marshall, W.; Liew, C. C.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent R00281501 by dynamic contrast enhanced MRI at 1.5T
    Meeting Abstract

    Muruganandham, M.; Lupu, M.; Dyke, J. P.; Matei, C.; Kolinsky, K.; Higgins, B.; Koutcher, J. A.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Phase 2 trials of SU1 1248 show antitumor activity in second-line therapy for patients with metastatic renal cell carcinoma (RCC)
    Meeting Abstract

    Motzer, R. J.; Rini, B. I.; Michaelson, M. D.; Redman, B. G.; Hudes, G. R.; Wilding, G.; Bukowski, R. M.; George, D. J.; Kim, S. T.; Baum, C. M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Sunitinib malate (SU11248) shows antitumour activity in patients with metastatic renal cell carcinoma: Updated results from phase II trials
    Meeting Abstract

    Motzer, R.; Rini, B.; Michaelson, M.; Redman, B.; Hudes, G.; Wilding, I.; Bukowski, R.; George, D.; Kim, S.; Baum, C.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • Phase II study of boriezomib for castrate metastatic prostate cancer (PC)
    Meeting Abstract

    Morris, M. J.; Beekman, K. W.; Kelly, W. K.; Slovin, S. F.; Shaffer, D.; Eicher, C.; Chu, E.; Curley, T.; Delacruz, A.; Scher, H. I.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Misbah, S. A.; Shaheen, P. E.; Elson, P. J.; Negrier, S.; Motzer, R. J.; Andresen, S. W.; Bukowski, R. M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Phase 1/2 dose escalation trial of the prostate-specific membrane antigen (PSMA)targeted immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Milowsky, M. I.; Galsky, M.; Lewin, J.; Rozario, C. P.; Owens, L.; Marshall, T.; Nanus, D.; Webb, I. J.; Scher, H. I.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Pharmacodynamic indicators of VEGF trap activity in patients with advanced solid tumors
    Meeting Abstract

    Lockhart, A. C.; Muruganandham, M.; Schwartz, L.; Koutcher, J.; Donnelly, E.; Andal, R.; Furfine, E. S.; Chevalier, P.; Spriggs, D. R.; Rothenberg, M. L.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Sequential dose-intensive paclitaxel plus ifosfamide and carboplatin plus etoposide with autologous stem cell transplantation for germ cell tumor (GCT) patients (pts)
    Meeting Abstract

    Kondagunta, G. V.; Bacik, J.; Bajorin, D. F.; Reich, L.; Sheinfeld, J.; Bains, M.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Population pharmacokinetic (PK)-pharmacodynamic (PD) meta-analysis of sunitinib malate (SU11248) efficacy and tolerability endpoints in gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma (MRCC) and solid tumor patients
    Meeting Abstract

    Houk, B. E.; Bello, C.; Garrett, M.; Poland, B.; Wagg, J.; Wada, R.; Motzer, R.; Rosen, L.; Demetri, G.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save